Renner, Kathrin
Bruss, Christina
Schnell, Annette
Koehl, Gudrun
Becker, Holger M.
Fante, Matthias
Menevse, Ayse-Nur
Kauer, Nathalie
Blazquez, Raquel
Hacker, Lisa
Decking, Sonja-Maria
Bohn, Toszka
Faerber, Stephanie
Evert, Katja
Aigle, Lisa
Amslinger, Sabine
Landa, Maria
Krijgsman, Oscar
Rozeman, Elisa A.
Brummer, Christina
Siska, Peter J.
Singer, Katrin
Pektor, Stefanie
Miederer, Matthias
Peter, Katrin
Gottfried, Eva
Herr, Wolfgang
Marchiq, Ibtisam
Pouyssegur, Jacques
Roush, William R.
Ong, SuFey
Warren, Sarah
Pukrop, Tobias
Beckhove, Philipp
Lang, Sven A.
Bopp, Tobias
Blank, Christian U.
Cleveland, John L.
Oefner, Peter J.
Dettmer, Katja
Selby, Mark
Kreutz, Marina
Funding for this research was provided by:
Moffitt Cancer Center (CRC1292, P30 CA076292)
Deutsche Forschungsgemeinschaft
National Institutes of Health
National Cancer Institute (CA175094)
This article is maintained by: Elsevier
Article Title: Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
Journal Title: Cell Reports
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.celrep.2019.08.068
Content Type: article
Copyright: © 2019 The Author(s).